Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial

David S. Lawrence; Nabila Youssouf; Síle F. Molloy; Alexandre Alanio; Melanie Alufandika; David R. Boulware; Timothée Boyer-Chammard; Tao Chen; Francoise Dromer; Admire Hlupeni; William Hope; Mina C. Hosseinipour; Cecilia Kanyama; Oliver Lortholary; Angela Loyse; David B. Meya; Mosepele Mosepele; Conrad Muzoora; Henry Mwandumba; Chiratidzo E. Ndhlovu; Louis Niessen; Charlotte Schutz; Katharine E. Stott; Duolao Wang; David Lalloo; Graeme Meintjes; Shabbar Jaffar; Thomas S. Harrison; Joseph N. Jarvis

doi:10.1186/s13063-018-3155-9

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial

David S. Lawrence, Nabila Youssouf, Síle F. Molloy, Alexandre Alanio, Melanie Alufandika, David R. Boulware, Timothée Boyer-Chammard, Tao Chen, Francoise Dromer, Admire Hlupeni, William Hope, Mina C. Hosseinipour, Cecilia Kanyama, Oliver Lortholary, Angela Loyse, David B. Meya, Mosepele Mosepele, Conrad Muzoora, Henry Mwandumba, Chiratidzo E. NdhlovuLouis Niessen, Charlotte Schutz, Katharine E. Stott, Duolao Wang, David Lalloo, Graeme Meintjes, Shabbar Jaffar, Thomas S. Harrison, Joseph N. Jarvis

Research output: Other contribution

2 Citations (Scopus)

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

Original language	English
Edition	1
Volume	20
DOIs	https://doi.org/10.1186/s13063-018-3155-9
Publication status	Published - 14 Jan 2019

Publication series

Name	Trials
Publisher	BioMed Central Ltd
ISSN (Print)	1745-6215

Access to Document

10.1186/s13063-018-3155-9Licence: CC BY

Fingerprint

Dive into the research topics of 'Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial'. Together they form a unique fingerprint.

2 Citations
1 Article

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
Ponatshego, P. L., Lawrence, D. S., Youssouf, N., Molloy, S. F., Alufandika, M., Bango, F., Boulware, D. R., Chawinga, C., Dziwani, E., Gondwe, E., Hlupeni, A., Hosseinipour, M. C., Kanyama, C., Meya, D. B., Mosepele, M., Muthoga, C., Muzoora, C. K., Mwandumba, H., Ndhlovu, C. E. & Rajasingham, R. & 18 others, Sayed, S., Shamu, S., Tsholo, K., Tugume, L., Williams, D., Maheswaran, H., Shiri, T., Boyer-Chammard, T., Loyse, A., Chen, T., Wang, D., Lortholary, O., Lalloo, D., Meintjes, G., Jaffar, S., Harrison, T. S., Jarvis, J. N. & Niessen, L., 1 Apr 2019, In: BMJ Open. 9, 4, p. e026288 e026288.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

Cite this

Lawrence, D. S., Youssouf, N., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., Boyer-Chammard, T., Chen, T., Dromer, F., Hlupeni, A., Hope, W., Hosseinipour, M. C., Kanyama, C., Lortholary, O., Loyse, A., Meya, D. B., Mosepele, M., Muzoora, C., Mwandumba, H., ... Jarvis, J. N. (2019, Jan 14). Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial. (1 ed.) https://doi.org/10.1186/s13063-018-3155-9

@misc{d813343f954e45e89e8dc424728c5f9b,

title = "Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial",

abstract = "Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.",

author = "Lawrence, \{David S.\} and Nabila Youssouf and Molloy, \{S{\'i}le F.\} and Alexandre Alanio and Melanie Alufandika and Boulware, \{David R.\} and Timoth{\'e}e Boyer-Chammard and Tao Chen and Francoise Dromer and Admire Hlupeni and William Hope and Hosseinipour, \{Mina C.\} and Cecilia Kanyama and Oliver Lortholary and Angela Loyse and Meya, \{David B.\} and Mosepele Mosepele and Conrad Muzoora and Henry Mwandumba and Ndhlovu, \{Chiratidzo E.\} and Louis Niessen and Charlotte Schutz and Stott, \{Katharine E.\} and Duolao Wang and David Lalloo and Graeme Meintjes and Shabbar Jaffar and Harrison, \{Thomas S.\} and Jarvis, \{Joseph N.\}",

year = "2019",

month = jan,

day = "14",

doi = "10.1186/s13063-018-3155-9",

language = "English",

volume = "20",

series = "Trials",

publisher = "BioMed Central Ltd",

edition = "1",

type = "Other",

}

Lawrence, DS, Youssouf, N, Molloy, SF, Alanio, A, Alufandika, M, Boulware, DR, Boyer-Chammard, T, Chen, T, Dromer, F, Hlupeni, A, Hope, W, Hosseinipour, MC, Kanyama, C, Lortholary, O, Loyse, A, Meya, DB, Mosepele, M, Muzoora, C, Mwandumba, H, Ndhlovu, CE, Niessen, L, Schutz, C, Stott, KE, Wang, D , Lalloo, D, Meintjes, G, Jaffar, S, Harrison, TS & Jarvis, JN 2019, Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial. https://doi.org/10.1186/s13063-018-3155-9

TY - GEN

T1 - Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial

AU - Lawrence, David S.

AU - Youssouf, Nabila

AU - Molloy, Síle F.

AU - Alanio, Alexandre

AU - Alufandika, Melanie

AU - Boulware, David R.

AU - Boyer-Chammard, Timothée

AU - Chen, Tao

AU - Dromer, Francoise

AU - Hlupeni, Admire

AU - Hope, William

AU - Hosseinipour, Mina C.

AU - Kanyama, Cecilia

AU - Lortholary, Oliver

AU - Loyse, Angela

AU - Meya, David B.

AU - Mosepele, Mosepele

AU - Muzoora, Conrad

AU - Mwandumba, Henry

AU - Ndhlovu, Chiratidzo E.

AU - Niessen, Louis

AU - Schutz, Charlotte

AU - Stott, Katharine E.

AU - Wang, Duolao

AU - Lalloo, David

AU - Meintjes, Graeme

AU - Jaffar, Shabbar

AU - Harrison, Thomas S.

AU - Jarvis, Joseph N.

PY - 2019/1/14

Y1 - 2019/1/14

N2 - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

AB - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

U2 - 10.1186/s13063-018-3155-9

DO - 10.1186/s13063-018-3155-9

M3 - Other contribution

VL - 20

T3 - Trials

ER -

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial

Abstract

Publication series

Access to Document

Fingerprint

Research output

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.

Cite this